Pyxis Oncology, Inc. (PYXS)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
1. 68
-0.12
-6.6667%
$
128.61M Market Cap
- P/E Ratio
- Div Yield
908,231 Volume
-0.91 Eps
$ 1.8
Previous Close 
Want to track PYXS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Pyxis Oncology, Inc. (PYXS) Statistics
Valuation metrics
Market Cap 128.61M
Enterprise value 127.59M
Trailing P/E (ttm) -1.44
Forward P/E -
PEG ratio -0.19
Price/Sales (ttm) 11.65
Price/Book (mrq) 11.36
Enterprise Value/Revenue 11.56
Enterprise Value/EBITDA -1.53
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 950.4K
Average volume (90 days) 896.91K
Price summary
52-Week low 1.03
52-Week high 5.55
Beta -
50-Day moving average 2.46
200-Day moving average 1.97
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -8.04%
Operating margin -8.34%
Operational effectiveness
Return on assets -1.62%
Return on equity -2.15%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.17
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.39
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.52
Total debt (mrq) -
Total Debt/Equity (mrq) 1.56
Current ratio (mrq) 1.34%
Book value per share (mrq) 0.18
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
